Award recordCONTRACT

BLOODSOLUTIONS MANAGERS, LLC

PIID 36C24924P0025· VHA· 249-NETWORK CONTRACT OFFICE 9 (36C249)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $377,262 net obligations· UEI Z9HUQ54LMDR4· TX

Description

BLOOD AND BLOOD PRODUCTS - VAMC MT. HOME.

First action · last action
2023-10-01 · 2025-08-15
Transactions
2
First transaction's obligation
$540,450
Base + all options value (sum of deltas)
$377,262
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I))
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$540,450$0Base award · 2023-10-01 · this action $540,450 · running total $540,450Modification P00001 · 2025-08-15 · this action -$163,188 · running total $377,262
  • Base2023-10-01+$540,450= $540,450
  • Mod P000012025-08-15-$163,188= $377,262
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2023-10-01+$540,450$540,450BLOOD AND BLOOD PRODUCTS - VAMC MT. HOME.
Mod P00001· FUNDING ONLY ACTION2025-08-15−$163,188$377,262BLOOD AND BLOOD PRODUCTS - VAMC MT. HOME.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI Z9HUQ54LMDR4)

AwardOffice · PSC / listingNet obligationsFY
36C24926A0003249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS$0FY2026
36C24926N0200249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS$594,875FY2026
36C24925P0025249-NETWORK CONTRACT OFFICE 9 (36C249) · 6506 · BLOOD AND BLOOD PRODUCTS$399,994FY2025
36C24923P0025249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$439,409FY2023
36C24922P0013249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$431,219FY2022
36C24921P0033249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$404,782FY2021

Other recipients under 6505 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24926N0676AMICUS THERAPEUTICS US, LLC249-NETWORK CONTRACT OFFICE 9 (36C249)$68,519FY2026
36C24926N0651BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$378,650FY2026
36C24926N0658BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026
36C24926N0590BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026
36C24926N0589BRISTOL-MYERS SQUIBB COMPANY249-NETWORK CONTRACT OFFICE 9 (36C249)$364,139FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24924P0025_3600_-NONE-_-NONE- · retrieved 2026-09-27.